Omega-3 and prostate cancer: examining the pertinent evidence

Mayo Clin Proc. 2014 Apr;89(4):444-50. doi: 10.1016/j.mayocp.2013.10.029. Epub 2014 Mar 6.

Authors

Mark F McCarty¹, James J DiNicolantonio², Carl J Lavie³, James H O'Keefe⁴

Affiliations

¹ Catalytic Longevity, Carlsbad, CA. Electronic address: markfmccarty@gmail.com.
² Mid-America Heart Institute at Saint Luke's Hospital, Kansas City, MO; Wegmans Pharmacy, Ithaca, NY.
³ John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, LA; Pennington Biomedical Research Center, Baton Rouge, LA.
⁴ Mid America Heart Institute, University of Missouri, Kansas City, MO.

PMID: 24613035
DOI: 10.1016/j.mayocp.2013.10.029

No abstract available

Publication types

Comment

MeSH terms

Fatty Acids, Omega-3 / adverse effects*
Fatty Acids, Omega-3 / blood*
Fatty Acids, Omega-6 / blood*
Humans
Male
Prostatic Neoplasms / diagnosis*
Prostatic Neoplasms / epidemiology*

Substances

Fatty Acids, Omega-3
Fatty Acids, Omega-6